225220 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
GENOLUTION, Inc. engages in the research and development of nucleic acid extractors. It operates through the Vitro Diagnostic and RNAi business divisions. The company was founded on February 20, 2006 and is headquartered in Seoul, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
225220 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company